Solventum reported Q3 2025 revenue of $2.096 billion and a net income of $1.266 billion. Despite slightly higher sales and strong results in segments like Dental and Health Information Systems, adjusted EPS declined. A one-time gain from the sale of the Purification and Filtration business significantly boosted GAAP earnings.
Revenue rose to $2.096 billion, a 0.7% increase from Q3 2024.
GAAP EPS surged to $7.22, boosted by a $1.5 billion gain on a business sale.
Adjusted EPS was $1.50, down from $1.64 in the prior year.
Free cash flow turned negative at -$22 million due to lower operating cash flow and increased capex.
Solventum raised full-year 2025 guidance, expecting organic sales growth at the high end of 2.0β3.0% and adjusted EPS between $5.98β$6.08.
Visualization of income flow from segment revenue to net income